453 related articles for article (PubMed ID: 23354242)
1. Recombinant tissue-type plasminogen activator-evoked hyperfibrinolysis is enhanced by acidosis and inhibited by hypothermia but still can be blocked by tranexamic acid.
Dirkmann D; Radü-Berlemann J; Görlinger K; Peters J
J Trauma Acute Care Surg; 2013 Feb; 74(2):482-8. PubMed ID: 23354242
[TBL] [Abstract][Full Text] [Related]
2. Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood.
Dirkmann D; Görlinger K; Gisbertz C; Dusse F; Peters J
Anesth Analg; 2012 Jun; 114(6):1182-8. PubMed ID: 22104068
[TBL] [Abstract][Full Text] [Related]
3. Hypothermia and acidosis synergistically impair coagulation in human whole blood.
Dirkmann D; Hanke AA; Görlinger K; Peters J
Anesth Analg; 2008 Jun; 106(6):1627-32. PubMed ID: 18499589
[TBL] [Abstract][Full Text] [Related]
4. Model of trauma-induced coagulopathy including hemodilution, fibrinolysis, acidosis, and hypothermia: Impact on blood coagulation and platelet function.
Shenkman B; Budnik I; Einav Y; Hauschner H; Andrejchin M; Martinowitz U
J Trauma Acute Care Surg; 2017 Feb; 82(2):287-292. PubMed ID: 27779583
[TBL] [Abstract][Full Text] [Related]
5. The effects of tranexamic acid and prothrombin complex concentrate on the coagulopathy of trauma: an in vitro analysis of the impact of severe acidosis.
Porta CR; Nelson D; McVay D; Salgar S; Eckert M; Izenberg S; Martin MJ
J Trauma Acute Care Surg; 2013 Dec; 75(6):954-60. PubMed ID: 24256666
[TBL] [Abstract][Full Text] [Related]
6. Plasmin thrombelastography rapidly identifies trauma patients at risk for massive transfusion, mortality, and hyperfibrinolysis: A diagnostic tool to resolve an international debate on tranexamic acid?
Barrett CD; Moore HB; Vigneshwar N; Dhara S; Chandler J; Chapman MP; Sauaia A; Moore EE; Yaffe MB
J Trauma Acute Care Surg; 2020 Dec; 89(6):991-998. PubMed ID: 33230046
[TBL] [Abstract][Full Text] [Related]
7. Influence of resuscitation fluids, fresh frozen plasma and antifibrinolytics on fibrinolysis in a thrombelastography-based, in-vitro, whole-blood model.
Kostousov V; Wang YW; Cotton BA; Wade CE; Holcomb JB; Matijevic N
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):489-97. PubMed ID: 23406662
[TBL] [Abstract][Full Text] [Related]
8. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
[TBL] [Abstract][Full Text] [Related]
9. Potential of whole blood coagulation reconstitution by desmopressin and fibrinogen under conditions of hypothermia and acidosis--an in vitro study using rotation thrombelastometry.
Hanke AA; Dellweg C; Schöchl H; Weber CF; Jüttner B; Johanning K; Görlinger K; Rahe-Meyer N; Kienbaum P
Scand J Clin Lab Invest; 2011 Jul; 71(4):292-8. PubMed ID: 21663556
[TBL] [Abstract][Full Text] [Related]
10. How do external factors contribute to the hypocoagulative state in trauma-induced coagulopathy? - In vitro analysis of the lethal triad in trauma.
Caspers M; Schäfer N; Fröhlich M; Bauerfeind U; Bouillon B; Mutschler M; Maegele M
Scand J Trauma Resusc Emerg Med; 2018 Aug; 26(1):66. PubMed ID: 30111342
[TBL] [Abstract][Full Text] [Related]
11. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
[TBL] [Abstract][Full Text] [Related]
12. Experimental model of hyperfibrinolysis designed for rotational thromboelastometry in children with congenital heart disease.
Faraoni D; Rozen L; Willems A; Torres CS; Pereira LM; Demulder A; Van der Linden P
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):290-7. PubMed ID: 25806960
[TBL] [Abstract][Full Text] [Related]
13. The α-globin chain of hemoglobin potentiates tissue plasminogen activator induced hyperfibrinolysis in vitro.
Morton AP; Hadley JB; Ghasabyan A; Kelher MR; Moore EE; Bevers S; Dzieciatkowska M; Hansen KC; Cohen MS; Banerjee A; Silliman CC
J Trauma Acute Care Surg; 2022 Jan; 92(1):159-166. PubMed ID: 34538821
[TBL] [Abstract][Full Text] [Related]
14. Tranexamic acid corrects fibrinolysis in the presence of acidemia in a swine model of severe ischemic reperfusion.
DeBarros M; Hatch Q; Porta CR; Salgar S; Izenberg S; DuBose J; Eckert M; Martin M
J Trauma Acute Care Surg; 2014 Mar; 76(3):625-32; discussion 632-3. PubMed ID: 24553528
[TBL] [Abstract][Full Text] [Related]
15. Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study.
Rozen L; Faraoni D; Sanchez Torres C; Willems A; Noubouossie DC; Barglazan D; Van der Linden P; Demulder A
Eur J Anaesthesiol; 2015 Dec; 32(12):844-50. PubMed ID: 26258658
[TBL] [Abstract][Full Text] [Related]
16. Wide temperature range testing with ROTEM coagulation analyses.
Kander T; Brokopp J; Friberg H; Schött U
Ther Hypothermia Temp Manag; 2014 Sep; 4(3):125-30. PubMed ID: 24933403
[TBL] [Abstract][Full Text] [Related]
17. 14-Day thawed plasma retains clot enhancing properties and inhibits tPA-induced fibrinolysis.
Huebner BR; Moore EE; Moore HB; Shepherd-Singh R; Sauaia A; Stettler GR; Nunns GR; Silliman CC
J Surg Res; 2017 Nov; 219():145-150. PubMed ID: 29078874
[TBL] [Abstract][Full Text] [Related]
18. Carbon monoxide releasing molecule-2 attenuates the anticoagulant and amplifies the hypofibrinolytic effects of hypothermia in human plasma in vitro.
Nielsen VG; George SJ
Blood Coagul Fibrinolysis; 2011 Jan; 22(1):67-72. PubMed ID: 21157299
[TBL] [Abstract][Full Text] [Related]
19. Acidosis impairs the coagulation: A thromboelastographic study.
Engström M; Schött U; Romner B; Reinstrup P
J Trauma; 2006 Sep; 61(3):624-8. PubMed ID: 16966998
[TBL] [Abstract][Full Text] [Related]
20. The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model.
Shenkman B; Livnat T; Lubetsky A; Tamarin I; Budnik I; Einav Y; Martinowitz U
Blood Coagul Fibrinolysis; 2012 Jul; 23(5):370-8. PubMed ID: 22498982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
